900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Cefixime 200mg/5mL oral suspension	A component that is no longer current, useful, appropriate or acceptable.
Cefixime overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefixime poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefmetazole product (product)	Ambiguous
Cefmetazole sodium 1g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefmetazole sodium 20mg/mL injection solution vial	A component that fails to comply with the current editorial guidance.
Cefmetazole sodium 2g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefmetazole sodium 40mg/mL injection solution vial	A component that fails to comply with the current editorial guidance.
Cefodizime overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefodizime poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefonicid sodium 10gm/vial powder for injection	A component that fails to comply with the current editorial guidance.
Cefonicid sodium 1g injection (pdr for recon)	A component that fails to comply with the current editorial guidance.
Cefonicid sodium 1g/vial powder for injection	A component that fails to comply with the current editorial guidance.
Cefoperazone + cefoperazone sodium 2gm/0ns injection	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone 2gm/cefoperazone sodium 0ns injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 10g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 1g injection (pdr for recon)	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 1g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 1g/bag injection	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 20mg/mL injection solution 50mL vial	A component that fails to comply with the current editorial guidance.
Cefoperazone sodium 2g injection (pdr for recon)	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 2g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 2g/bag injection	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 2gm/50mL conventional release solution for infusion	A component that is no longer current, useful, appropriate or acceptable.
Cefoperazone sodium 2gm/50mL infusion	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime + cefotaxime sodium 2ns/0gm injection	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime 2g injection (pdr for recon)	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime 2g powder for infusion solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime 2ns/cefotaxime 0gm injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefotaxime poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefotaxime sodium 10g infusion solution bottle	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime sodium 1g injection	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefotaxime sodium 1g powder for injection solution vial	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefotaxime sodium 1gm/50mL conventional release solution for infusion	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime sodium 1gm/50mL infusion	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime sodium 2g injection	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime sodium 2g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime sodium 2gm/50mL conventional release solution for infusion	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime sodium 2gm/50mL infusion	A component that is no longer current, useful, appropriate or acceptable.
Cefotaxime sodium 500mg powder for injection solution vial	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefotetan disodium 10g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefotetan disodium 1g/vial powder	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefotetan disodium 20mg/mL infusion solution 50mL vial	A component that fails to comply with the current editorial guidance.
Cefotetan disodium 40mg/mL infusion solution 50mL vial	A component that fails to comply with the current editorial guidance.
Cefoxitin + dextrose	Ambiguous
Cefoxitin 2g powder for injection solution vial	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefoxitin sodium 10g powder for injection solution vial	A component that is no longer current, useful, appropriate or acceptable.
Cefoxitin sodium 2g injection solution 50mL bag	A component that fails to comply with the current editorial guidance.
Cefpirome overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefpirome poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefpodoxime 100mg/5mL oral suspension	A component that is no longer current, useful, appropriate or acceptable.
Cefpodoxime 200mg tablet	A component that is no longer current, useful, appropriate or acceptable.
Cefpodoxime 40mg/5mL pediatric suspension	Ambiguous
Cefpodoxime 50mg/5mL oral suspension	A component that is no longer current, useful, appropriate or acceptable.
Cefpodoxime overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefpodoxime poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefpodoxime proxetil 100mg tablet	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefpodoxime proxetil 50mg/5mL suspension	A component that is no longer current, useful, appropriate or acceptable.
Cefprozil 125mg/5mL oral suspension	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefprozil 125mg/5mL suspension	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefprozil 250mg/5mL powder for oral suspension	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefprozil 250mg/5mL suspension	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefsulodin overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cefsulodin poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftazidime (arginine formula) 10g/vial injection	A component that fails to comply with the current editorial guidance.
Ceftazidime (arginine formula) 10g/vial powder for injection	A component that fails to comply with the current editorial guidance.
Ceftazidime (arginine formula) 1g/vial injection	A component that fails to comply with the current editorial guidance.
Ceftazidime (arginine formula) 1g/vial powder for injection	A component that fails to comply with the current editorial guidance.
Ceftazidime (arginine formula) 2g/vial injection	A component that fails to comply with the current editorial guidance.
Ceftazidime (arginine formula) 2g/vial powder for injection	A component that fails to comply with the current editorial guidance.
Ceftazidime (arginine formula) 6g/100mL powder for injection 100mL vial	A component that fails to comply with the current editorial guidance.
Ceftazidime	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ceftazidime 100g/vial powder	A component that fails to comply with the current editorial guidance.
Ceftazidime 10g infusion solution vial	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 10g/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 1g injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 1g powder for injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 1g/100mL	A component that fails to comply with the current editorial guidance.
Ceftazidime 1g/100mL injection	A component that fails to comply with the current editorial guidance.
Ceftazidime 1g/100mL powder for injection 100mL vial	A component that fails to comply with the current editorial guidance.
Ceftazidime 1g/25mL injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 1g/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 1g/vial powder	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 2000mg infusion solution vial	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 2g injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 2g powder	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 2g powder for infusion solution vial	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 2g/100mL	A component that fails to comply with the current editorial guidance.
Ceftazidime 2g/50mL injection	A component that fails to comply with the current editorial guidance.
Ceftazidime 2g/50mL powder for injection 50mL vial	A component that fails to comply with the current editorial guidance.
Ceftazidime 2g/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 2gm/vil powder	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 500mg infusion solution vial	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 500mg injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 500mg powder for injection 10mL vial	A component that fails to comply with the current editorial guidance.
Ceftazidime 500mg/15mL injection	A component that fails to comply with the current editorial guidance.
Ceftazidime 500mg/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Ceftazidime 6g injection	A component that fails to comply with the current editorial guidance.
Ceftazidime 6g/100mL injection	A component that fails to comply with the current editorial guidance.
Ceftazidime 6g/vial injection	A component that fails to comply with the current editorial guidance.

Start Previous Page 230 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)